title: Myelofibrosis, JAK2 inhibitors and erythropoiesis.
authors.forename: W
authors.initials: W
authors.lastname: Vainchenker
authors.forename: F
authors.initials: F
authors.lastname: Favale
mesh_terms: D001549:Benzamides / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053613:Janus Kinase 1 / Q000037:antagonists & inhibitors*; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors*; D008297:Male; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D001549:Benzamides; D011743:Pyrimidines; C546012:N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide; D053613:Janus Kinase 1; D053614:Janus Kinase 2